scispace - formally typeset
R

Roger G. Ptak

Researcher at Southern Research Institute

Publications -  76
Citations -  2522

Roger G. Ptak is an academic researcher from Southern Research Institute. The author has contributed to research in topics: Viral replication & Small molecule. The author has an hindex of 26, co-authored 71 publications receiving 2257 citations. Previous affiliations of Roger G. Ptak include Scripps Research Institute.

Papers
More filters
Journal ArticleDOI

Cataloguing the HIV type 1 human protein interaction network

TL;DR: This database represents a unique and continuously updated scientific resource for understanding HIV-1 replication and pathogenesis to assist in accelerating the development of effective therapeutic and vaccine interventions.
Journal ArticleDOI

Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

TL;DR: Debio-025 seems to interfere with the function of CypA during the progression/completion of HIV-1 reverse transcription, and by real-time PCR it is demonstrated that early reverse transcription is reduced in the presence of Debo-025 and that late reverse transcription was almost completely blocked.
Journal ArticleDOI

HIV-1, human interaction database: current status and new features

TL;DR: A redesigned web interface is introduced to enhance viewing, filtering and downloading of the combined data set of HIV-1 protein–human protein interactions and the inclusion of siRNA interactions.
Journal ArticleDOI

Antiviral Activity of Hop Constituents Against a Series of DNA and RNA Viruses

TL;DR: In summary, iso-alpha-acids and xanthohumol were shown to have a low-to-moderate antiviral activity against several viruses and might serve as interesting lead compounds from which more active anti-HCV, anti-Rhino and anti-herpesvirus antiviral agents could be synthesized.
Journal ArticleDOI

Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication

TL;DR: Results indicate that MOV10 has a broad antiretroviral activity that can target a wide range of retroviruses, and it could be actively involved in host defense against retroviral infection.